AYTU BIOPHARMA, INC Professional Fees
AYTU BIOPHARMA, INC (AYTU) reported Professional Fees of $3.36 thousand for the 3-month period ending 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2015-04-15
- AYTU BIOPHARMA, INC professional fees for the quarter ending 2015-02-28 was $3.36K, a 77.70% decline year-over-year.
- AYTU BIOPHARMA, INC professional fees for the quarter ending 2014-11-30 was $8.37K, a 15.47% increase year-over-year.
- AYTU BIOPHARMA, INC professional fees for the quarter ending 2014-05-31 was $6.12K, a 167.07% increase year-over-year.
- AYTU BIOPHARMA, INC professional fees for the quarter ending 2014-02-28 was $15.09K, a 343.45% increase year-over-year.
- AYTU BIOPHARMA, INC professional fees for fiscal 2013 was $18.08K, a 5.20% increase from fiscal 2012.
- AYTU BIOPHARMA, INC professional fees for fiscal 2012 was $17.19K, a 61.54% decline from fiscal 2011.
- AYTU BIOPHARMA, INC professional fees for fiscal 2011 was $44.69K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month | Professional Fees 12 month as first filed | Professional Fees 81 month | Professional Fees 84 month | Professional Fees 87 month | Professional Fees 90 month | Professional Fees 93 month | Professional Fees 96 month | Professional Fees 99 month | Professional Fees 102 month | Professional Fees 105 month | Professional Fees 108 month | Professional Fees 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-28 | $3.36K 10-Q · filed 2015-04-15 | $11.73K 10-Q · filed 2015-04-15 | ||||||||||||||
| 2014-11-30 | $8.37K 10-Q · filed 2015-01-12 | |||||||||||||||
| 2014-05-31 | $6.12K 10-Q · filed 2014-07-10 | $21.20K derived: sum of 2 quarters · filed 2015-04-15 | $28.45K 10-Q · filed 2014-07-10 | $31.13K derived: sum of 4 quarters · filed 2015-04-15 | $199.13K 10-Q · filed 2014-07-10 | |||||||||||
| 2014-02-28 | $15.09K 10-Q · filed 2015-04-15 | $22.33K 10-Q · filed 2015-04-15 | $25.01K derived: sum of 3 quarters · filed 2015-04-15 | $27.30K derived: sum of 4 quarters · filed 2015-04-15 | $193.01K 10-Q · filed 2014-04-11 | |||||||||||
| 2013-11-30 | $7.25K 10-Q · filed 2015-01-12 | $9.93K derived: sum of 2 quarters · filed 2015-01-12 | $12.22K derived: sum of 3 quarters · filed 2015-01-12 | $15.62K derived: sum of 4 quarters · filed 2015-01-12 | $177.93K 10-Q · filed 2014-01-10 | |||||||||||
| 2013-08-31 | $2.68K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $4.97K derived: sum of 2 quarters · filed 2014-11-26 | $8.37K derived: sum of 3 quarters · filed 2014-11-26 | $18.08K 10-K · filed 2014-11-26 | $170.68K 10-K · filed 2014-11-26 | |||||||||||
| 2013-05-31 | $2.29K 10-Q · filed 2014-07-10 | $5.69K derived: sum of 2 quarters · filed 2014-04-11 | $15.40K 10-Q · filed 2014-07-10 | $16.59K derived: sum of 4 quarters · filed 2014-11-26 | $168.00K 10-Q · filed 2013-06-28 | |||||||||||
| 2013-02-28 | $3.40K 10-Q · filed 2014-04-11 | $13.11K 10-Q · filed 2014-04-11 | $14.30K derived: sum of 3 quarters · filed 2014-11-26 | $17.81K derived: sum of 4 quarters · filed 2014-11-26 | $165.71K 10-Q · filed 2013-04-15 | |||||||||||
| 2012-11-30 | $9.71K 10-Q · filed 2014-01-10 | $10.89K derived: sum of 2 quarters · filed 2014-11-26 | $14.41K derived: sum of 3 quarters · filed 2014-11-26 | $18.46K derived: sum of 4 quarters · filed 2014-11-26 | $162.31K 10-Q · filed 2013-01-14 | |||||||||||
| 2012-08-31 | $1.19K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $4.71K derived: sum of 2 quarters · filed 2014-11-26 | $8.75K derived: sum of 3 quarters · filed 2014-11-26 | $17.19K 10-K · filed 2014-11-26 | $20.08K 10-K · filed 2012-11-29 | $152.60K 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | $3.52K 10-Q · filed 2012-06-26 | $7.56K derived: sum of 2 quarters · filed 2013-06-28 | $16.00K 10-Q · filed 2013-06-28 | $148.51K 10-Q · filed 2012-06-26 | ||||||||||||
| 2012-02-29 | $4.05K 10-Q · filed 2012-04-12 | $12.48K 10-Q · filed 2013-04-15 | $145.00K 10-Q · filed 2012-04-12 | |||||||||||||
| 2012-02-28 | $4.05K 10-Q · filed 2013-04-15 | $12.48K derived: sum of 2 quarters · filed 2013-04-15 | $37.68K derived: sum of 3 quarters · filed 2013-04-15 | $42.57K derived: sum of 4 quarters · filed 2013-04-15 | ||||||||||||
| 2011-11-30 | $8.43K 10-Q · filed 2013-01-14 | $33.63K derived: sum of 2 quarters · filed 2013-01-14 | $38.52K derived: sum of 3 quarters · filed 2013-01-14 | $45.57K derived: sum of 4 quarters · filed 2013-01-14 | $140.95K 10-Q · filed 2011-12-23 | |||||||||||
| 2011-08-31 | $25.20K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $30.09K derived: sum of 2 quarters · filed 2012-11-29 | $37.14K derived: sum of 3 quarters · filed 2012-11-29 | $44.69K 10-K · filed 2012-11-29 | ||||||||||||
| 2011-05-31 | $4.89K 10-Q · filed 2012-06-26 | $11.94K derived: sum of 2 quarters · filed 2012-06-26 | $19.49K 10-Q · filed 2012-06-26 | |||||||||||||
| 2011-02-28 | $7.05K 10-Q · filed 2012-04-12 | $14.60K 10-Q · filed 2012-04-12 | ||||||||||||||
| 2010-11-30 | $7.55K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |